Patents by Inventor Minkui Luo

Minkui Luo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADENOSINE ANALOGS AS METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER
    Publication number: 20230135822
    Abstract: Compounds having methyltransferase inhibitory activity are disclosed. The compounds have the structures The compounds disclosed are useful in the treatment of cancer and similar diseases associated with inappropriate methyltransferase activity.
    Type: Application
    Filed: September 26, 2022
    Publication date: May 4, 2023
    Applicant: MEMORIAL SLOAN KETTERING CANCER CENTER
    Inventors: Minkui LUO, Xiaochuan CAI, Ke WANG, Junyi WANG
  • Adenosine analogs as methyltransferase inhibitors for treating cancer
    Patent number: 11453696
    Abstract: Compounds having methyltransferase inhibitory activity are disclosed. The compounds have the structures The compounds disclosed are useful in the treatment of cancer and similar diseases associated with inappropriate methyltransferase activity.
    Type: Grant
    Filed: August 3, 2020
    Date of Patent: September 27, 2022
    Assignee: MEMORIAL SLOAN KETTERING CANCER CENTER
    Inventors: Minkui Luo, Xiaochuan Cai, Ke Wang, Junyi Wang
  • ADENOSINE ANALOGS AS METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER
    Publication number: 20210017216
    Abstract: Compounds having methyltransferase inhibitory activity are disclosed. The compounds have the structures The compounds disclosed are useful in the treatment of cancer and similar diseases associated with inappropriate methyltransferase activity.
    Type: Application
    Filed: August 3, 2020
    Publication date: January 21, 2021
    Applicant: MEMORIAL SLOAN KETTERING CANCER CENTER
    Inventors: Minkui LUO, Xiaochuan CAI, Ke WANG, Junyi WANG
  • Adenosine analogs as methyltransferase inhibitors for treating cancer
    Patent number: 10730903
    Abstract: Compounds having methyltransferase inhibitory activity are disclosed. The compounds have the structures The compounds disclosed are useful in the treatment of cancer and similar diseases associated with inappropriate methyltransferase activity.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: August 4, 2020
    Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Minkui Luo, Xiaochuan Cai, Ke Wang, Junyi Wang
  • ADENOSINE ANALOGS AS METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER
    Publication number: 20190276488
    Abstract: Compounds having methyltransferase inhibitory activity are disclosed. The compounds have the structures The compounds disclosed are useful in the treatment of cancer and similar diseases associated with inappropriate methyltransferase activity.
    Type: Application
    Filed: September 15, 2017
    Publication date: September 12, 2019
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Minkui LUO, Xiaochuan CAI, Ke WANG, Junyi WANG
  • COFACTOR ANALOGS AS METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER
    Publication number: 20180305391
    Abstract: Compounds having methyltransferase inhibitory activity are disclosed. The compounds have the structure They are useful in the treatment of cancer and similar diseases associated with inappropriate methyltransferase activity.
    Type: Application
    Filed: October 21, 2016
    Publication date: October 25, 2018
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Minkui LUO, Xiaochuan CAI, Ke WANG, Michaelyn LUX
  • Methyltransferase inhibitors for treating cancer
    Patent number: 9493501
    Abstract: Compounds having methyltransferase inhibitory activity are disclosed. The compounds have the structure and are useful in the treatment of cancer and similar diseases associated with inappropriate methyltransferase activity.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: November 15, 2016
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: Weihong Zheng, Minkui Luo, Glorymar del Valle Ibanez Sanchez
  • METHYLTRANSFERASE INHIBITORS FOR TREATING CANCERS
    Publication number: 20160052955
    Abstract: Compounds having methyltransferase inhibitory activity are disclosed. The compounds have the structure and are useful in the treatment of cancer and similar diseases associated with inappropriate methyltransferase activity.
    Type: Application
    Filed: April 15, 2014
    Publication date: February 25, 2016
    Applicant: SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
    Inventors: Minkui LUO, Weihong ZHENG
  • METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER
    Publication number: 20140303106
    Abstract: Compounds having methyltransferase inhibitory activity are disclosed. The compounds have the structure and are useful in the treatment of cancer and similar diseases associated with inappropriate methyltransferase activity.
    Type: Application
    Filed: October 26, 2012
    Publication date: October 9, 2014
    Inventors: Weihong Zheng, Minkui Luo, Glorymar del Valle Ibanzen Sanchez